KBC Group NV Reduces Stake in Prestige Consumer Healthcare by 10.5% in Q1

August 12, 2023

🌥️Trending News

KBC Group NV, an institutional investor, recently reduced its ownership of Prestige Consumer Healthcare ($NYSE:PBH) Inc. in the first quarter of this year by 10.5%. The move has been seen as a possible indication of a shift in investor sentiment regarding the company. Prestige Consumer Healthcare Inc. is an American multinational consumer packaged goods holding company that manufactures, markets and distributes over-the-counter drugs, nutritional products and personal care products. The company has a long history of value creation and is committed to providing a wide range of products that meet the needs of consumers.

Its portfolio includes well-known brands such as Chloraseptic, Little Remedies, Luden’s, Bodycology, Comet and more. It could also reflect their concerns about the challenges facing the industry in the near future. It is unclear at this time what the long-term effects will be, but it is clear that investors are taking a cautious approach with their investments.


GoodWhale has conducted an analysis of PRESTIGE CONSUMER HEALTHCARE’s wellbeing. According to our Star Chart, PRESTIGE CONSUMER HEALTHCARE is strong in profitability, but weak in asset, dividend and growth. Based on this analysis, we have classified PRESTIGE CONSUMER HEALTHCARE as a ‘sloth’, a type of company which has achieved revenue or earnings growth slower than the overall economy. Given its weak growth and low risk profile, PRESTIGE CONSUMER HEALTHCARE may appeal to investors who are looking for companies that have a steady track record of providing consistent returns. Additionally, PRESTIGE CONSUMER HEALTHCARE has a high health score of 7/10 considering its cashflows and debt, so it is capable to safely ride out any crisis without the risk of bankruptcy. In view of these factors, investors who are looking for stability and reliable returns may be interested in investing in PRESTIGE CONSUMER HEALTHCARE. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis
  • About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for PBH. More…

    Total Revenues Net Income Net Margin
    1.13k -84.3 21.3%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for PBH. More…

    Operations Investing Financing
    219.56 -8.21 -192.65
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for PBH. More…

    Total Assets Total Liabilities Book Value Per Share
    3.35k 1.87k 29.88
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for PBH are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    5.6% 4.9% -2.2%
    FCF Margin ROE ROA
    18.7% -1.0% -0.5%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items

  • Peers

    The company’s main competitors are Galenica Ltd., Guangdong Kanghua Healthcare Co Ltd, and Mednow Inc.

    – Galenica Ltd. ($LTS:0ROG)

    Galenica Ltd. is a Swiss pharmaceutical company with a market cap of 3.43B as of 2022. The company has a return on equity of 11.13%. Galenica Ltd. is a pharmaceutical company that focuses on the development, production, and marketing of drugs and medical devices.

    – Guangdong Kanghua Healthcare Co Ltd ($SEHK:03689)

    Kanghua Healthcare is a leading healthcare company in China with a market cap of over $600 million. The company has a strong focus on research and development and has a strong portfolio of products. The company’s return on equity is 4.5%. Kanghua Healthcare is a well-respected company in the healthcare industry and is a great investment for long-term growth.

    – Mednow Inc ($TSXV:MNOW)

    Mednow Inc is a company that provides medical supplies and services. The company has a market capitalization of $8.63 million and a return on equity of -91.28%. The company’s products and services include medical equipment, supplies, and services. Mednow Inc is headquartered in the United States.


    This indicates that KBC Group NV may have lost faith in the performance of Prestige Consumer Healthcare and decided to decrease their investment by distributing a portion of their shares. Investors should take note and pay attention to Prestige Consumer Healthcare’s performance going forward. Additionally, analysts should consider the impact of this decrease in investment on Prestige Consumer Healthcare’s future stock price.

    Recent Posts

    Leave a Comment